Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Lotze

Showing results (141-150 of 242) with videos related to

Pageof 25
Sort By:
Cancer Gene Therapy|April 15, 2000
Characterization and transduction of a retroviral vector encoding human interleukin-4 and herpes simplex virus-thymidine kinase for glioma tumor vaccine therapyH Okada, J Attanucci, H Tahara, et al.
Radiology|November 1, 1988
Fournier gangrene: diagnosis with scrotal USM G Begley, T H Shawker, C N Robertson, et al.
Leukemia|December 27, 2014
You eat what you are: autophagy inhibition as a therapeutic strategy in leukemiaA R Sehgal, H Konig, D E Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Generation of anti-p53 cytotoxic T lymphocytes from human peripheral blood using autologous dendritic cellsK Chikamatsu, K Nakano, W J Storkus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999
Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectivelyW Hashimoto, T Osaki, H Okamura, et al.
Cancer Research|January 1, 1995
Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyteM A Frassanito, J I Mayordomo, R M DeLeo, et al.
The Journal of Surgical Research|February 1, 1995
Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapyI Pappo, H Tahara, P D Robbins, et al.
European Journal of Immunology|September 29, 2000
Interleukin-12 and Flt3 ligand differentially promote dendropoiesis in vivoC Esche, Q Cai, J M Peron, et al.
The Journal of Investigative Dermatology|December 14, 1999
Differential regulation of epidermal and dermal dendritic cells by IL-12 and Flt3 ligandC Esche, V M Subbotin, O Hunter, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Transfer and expression of the human interleukin-4 gene in carcinoma and stromal cell lines derived from lung cancer patientsJ D Hunt, B A Pippin, R J Landreneau, et al.
Pageof 25

Showing results (141-150 of 242) with videos related to

Sort By:
Pageof 25
Cancer Gene Therapy|April 15, 2000
Characterization and transduction of a retroviral vector encoding human interleukin-4 and herpes simplex virus-thymidine kinase for glioma tumor vaccine therapyH Okada, J Attanucci, H Tahara, et al.
Radiology|November 1, 1988
Fournier gangrene: diagnosis with scrotal USM G Begley, T H Shawker, C N Robertson, et al.
Leukemia|December 27, 2014
You eat what you are: autophagy inhibition as a therapeutic strategy in leukemiaA R Sehgal, H Konig, D E Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Generation of anti-p53 cytotoxic T lymphocytes from human peripheral blood using autologous dendritic cellsK Chikamatsu, K Nakano, W J Storkus, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 8, 1999
Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectivelyW Hashimoto, T Osaki, H Okamura, et al.
Cancer Research|January 1, 1995
Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyteM A Frassanito, J I Mayordomo, R M DeLeo, et al.
The Journal of Surgical Research|February 1, 1995
Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapyI Pappo, H Tahara, P D Robbins, et al.
European Journal of Immunology|September 29, 2000
Interleukin-12 and Flt3 ligand differentially promote dendropoiesis in vivoC Esche, Q Cai, J M Peron, et al.
The Journal of Investigative Dermatology|December 14, 1999
Differential regulation of epidermal and dermal dendritic cells by IL-12 and Flt3 ligandC Esche, V M Subbotin, O Hunter, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Transfer and expression of the human interleukin-4 gene in carcinoma and stromal cell lines derived from lung cancer patientsJ D Hunt, B A Pippin, R J Landreneau, et al.
Pageof 25